Michelle McMurry-Heath, MD, PhD
“Society will rise or fall on the ingenuity of our scientists, the vibrancy of our innovative ecosystem, and the personal courage of the men and women working day and night to bring cures to patients, food to tables and relief to our environment.”
Michelle McMurry-Heath is the CEO and President of the Biotechnology Innovation Organization (BIO), the world’s largest biotechnology advocacy group representing 1,000 life science companies and organizations from 30 countries and supporting scientific breakthroughs that improve human health, environmental stewardship, and sustainable agriculture.
A medical doctor and molecular immunologist by training, McMurry-Heath now focuses on broadening access to scientific progress so more patients from diverse backgrounds can benefit from cutting-edge innovation.
Previously, McMurry-Heath held numerous senior roles at Johnson & Johnson as the Vice President of External Innovation, Executive Director of Scientific Partnerships for JLABS@DC, Worldwide Vice President of Regulatory and Clinical Affairs, and Global Head of Evidence Generation.
She also led science policy development as the Associate Science Director of the U.S. Food and Drug Administration’s Center for Devices and Radiological Health, where she championed clinical trial evolution, the use of real-world evidence in product evaluation, and the patient voice in health research. As the Founding Director of the Aspen Institute’s Health, Biomedical Science, and Society Policy Program, McMurry-Heath promoted personalized medicine and bolstered international preparation for pandemic disease threats. She also drafted legislation to protect the U.S. from biological attacks as Senator Joe Lieberman’s top legislative aide for science and health.
After obtaining her B.A. in biochemistry and molecular biology from Harvard University, McMurry-Heath became the first African-American to receive her M.D. and Ph.D. upon graduation from the Duke Medical Scientist Training Program.